An Embryonic Disaster?
By Isabel Oakeshott and Sarah-Kate Templeton,
The Sunday Times
| 03. 16. 2008
The government’s new fertility bill is under fire on religious, moral and even scientific grounds
When Liz Shipley was diagnosed with motor neurone disease (MND) it came as
little surprise. The 36-year-old from Newcastle had lost her mother to the
same condition when she was just three years old. Several other members of
her family, including her sister and uncle, had died or were suffering from
the muscle-wasting disease.
Ten years on and unable to walk, write or dress herself, she fears that her
two teenage children will also inherit the disease. Shipley does not expect
a cure in her lifetime but she backs controversial scientific research using
embryos that are part-human, part-animal, which could lead to a treatment
for her children if they are struck down.
“When you have an illness for which there is no cure, you have to investigate
every avenue,” said Shipley. “I do not want my children to be told in 20
years’ time that they have MND and there is still no cure. I believe the
answers will lie in stem cells of some kind. Hopefully this research will be
able to tell us why this is happening to...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...